NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Anastasia Ivanova
University of North Carolina Chapel Hill - Chapel Hill / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 1557435
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Anastasia Ivanova's MOST POPULAR ARTICLES
1-)
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort studyEC Rossi, LD Kowalski, J Scalici, L Cantrell, K Schuler, RK Hanna, ...The Lancet Oncology 18 (3), 384-392, 20176132017
2-)
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancerLA Carey, HS Rugo, PK Marcom, EL Mayer, FJ Esteva, CX Ma, MC Liu, ...Journal of clinical oncology 30 (21), 2615, 20125532012
3-)
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignanciesRZ Orlowski, PM Voorhees, RA Garcia, MD Hall, FJ Kudrik, T Allred, ...Blood 105 (8), 3058-3065, 20054002005
4-)
A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patientsSS Carson, JP Kress, JE Rodgers, A Vinayak, S Campbell-Bright, J Levitt, ...Critical care medicine 34 (5), 1326-1332, 20063712006
5-)
Risk factors for recurrent urinary tract infection and renal scarringR Keren, N Shaikh, H Pohl, L Gravens-Mueller, A Ivanova, L Zaoutis, ...Pediatrics 136 (1), e13-e21, 20153632015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept